Sciencast Management’s Globus Medical GMED Stock Holding History

Sciencast Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,198	Closed	-$793K	–	298
2026 Q1	$793K	Buy	+9,198	New	+$826K	0.1%	193
2024 Q3	–	Sell	-10,689	Closed	-$732K	–	287
2024 Q2	$732K	Buy	+10,689	New	+$639K	0.25%	148
2023 Q3	–	Sell	-6,185	Closed	-$356K	–	389
2023 Q2	$356K	Buy	+6,185	New	+$352K	0.29%	145
2022 Q2	–	Sell	-4,033	Closed	-$301K	–	485
2022 Q1	$301K	Buy	+4,033	New	+$280K	0.07%	305
2021 Q1	–	Sell	-17,849	Closed	-$1.19M	–	562
2020 Q4	$1.19M	Buy	+17,849	New	+$1.03M	0.25%	133
2018 Q2	–	Sell	-4,010	Closed	-$202K	–	301
2018 Q1	$202K	Buy	+4,010	New	+$188K	0.1%	302
2017 Q3	–	Sell	-9,100	Closed	-$302K	–	370
2017 Q2	$302K	Buy	+9,100	New	+$286K	0.17%	225

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sciencast Management's GMED Position: Q2 2026 in Review

Sciencast Management sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 9,198 shares — an estimated $793K sold.

Sciencast Management first reported a position in GMED in Q2 2017 and held it in 7 quarters. The position peaked at $1.19M in Q4 2020. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Sciencast Management reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
Sciencast Management sold 9,198 Globus Medical shares in Q2 2026, an estimated $793K.
Sciencast Management first reported a position in Globus Medical in Q2 2017 and held it in 7 quarters.
Sciencast Management's Globus Medical position peaked at $1.19M in Q4 2020.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Sciencast Management's 13F filing for Q2 2026, filed 28 Jul 2026.